Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma

dc.contributor.authorKylmä Anna Kaisa
dc.contributor.authorSorsa Timo
dc.contributor.authorJouhi Lauri
dc.contributor.authorMustonen Harri K
dc.contributor.authorMohamed Hesham
dc.contributor.authorRandén-Brady Reija
dc.contributor.authorMäkitie Antti
dc.contributor.authorAtula Timo
dc.contributor.authorHagström Jaana
dc.contributor.authorHaglund Caj
dc.contributor.organizationfi=hammaslääketieteen laitos|en=Institute of Dentistry|
dc.contributor.organization-code1.2.246.10.2458963.20.64787032594
dc.converis.publication-id177261669
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/177261669
dc.date.accessioned2022-12-15T03:31:34Z
dc.date.available2022-12-15T03:31:34Z
dc.description.abstract<p>BACKGROUND / AIM</p><p>The oral bacteria involved in the development of periodontitis alter the tissue conditions and modify immune responses in a way that may also influence tumor development. We investigated the prevalence of R gingipain (Rgp), a key virulence factor of the oral pathobiont Porphyromonas gingivalis, and the tissue-destructive enzymes matrix metalloproteinase 8 (MMP-8) and 9 (MMP-9) in 202 unselected consecutive oropharyngeal squamous cell carcinoma (OPSCC) samples. We further investigated the relationships between these factors and human papillomavirus (HPV) status, Treponema denticola chymotrypsin-like proteinase (Td-CTLP) immunoexpression, clinical parameters, and patient outcome.<br></p><p>PATIENTS AND METHODS<br></p><p>Clinicopathological data were derived from university hospital records. Rgp, MMP-8, and MMP-9 immunoexpression was evaluated by immunohistochemistry; the immunohistochemistry of Td-CTLP and HPV has been described earlier for this patient series. Cox regression analysis including death by causes other than OPSCC as a competing risk served to assess sub distribution hazard ratios.<br></p><p>RESULTS</p><p>In multivariable survival analysis, positive tumoral MMP-9 immunoexpression predicted poor prognosis among all patients [sub distribution hazard ratio (SHR)=2.4; confidence interval (CI)=1.2-4.4, p=0.008], and especially among those with HPV-negative OPSCC (SHR=3.5; CI=1.7-7.3, p=0.001). Positive immunoexpression of Rgp in inflammatory cells was associated with favorable outcome among all patients (SHR=0.5, CI=0.2-0.9, p=0.021) and among those with HPV-negative disease (SHR=0.4, CI=0.2-0.9, p=0.022).<br></p><p>CONCLUSION</p><p>Our results suggest that tumoral MMP-9 may be related to poor outcome in OPSCC, especially in HPV-negative disease, while Rgp immunoexpression in inflammatory cells is associated here with better disease-specific survival (DSS).</p>
dc.format.pagerange5415
dc.format.pagerange5430
dc.identifier.eissn1791-7530
dc.identifier.jour-issn0250-7005
dc.identifier.olddbid190608
dc.identifier.oldhandle10024/173699
dc.identifier.urihttps://www.utupub.fi/handle/11111/31405
dc.identifier.urlhttps://ar.iiarjournals.org/content/42/11/5415
dc.identifier.urnURN:NBN:fi-fe2022121571601
dc.language.isoen
dc.okm.affiliatedauthorHagström, Jaana
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherInternational Institute of Anticancer Research
dc.publisher.countryGreeceen_GB
dc.publisher.countryKreikkafi_FI
dc.publisher.country-codeGR
dc.relation.doi10.21873/anticanres.16046
dc.relation.ispartofjournalAnticancer Research
dc.relation.issue11
dc.relation.volume42
dc.source.identifierhttps://www.utupub.fi/handle/10024/173699
dc.titlePrognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
5415.full.pdf
Size:
2.47 MB
Format:
Adobe Portable Document Format